We have recently shown that B cells from human melanoma are not only essential to sustain inflammation and CD8+ T cell numbers in the tumor microenvironment but also can directly augment T cell activation by immune checkpoint blockade (Griss et al., 2019). The gene discussed is CD8A; the disease is melanoma.